Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Strictly: Drilling II -- Ignore unavailable to you. Want to Upgrade?

To: russwinter who wrote (10885)	4/19/2002 3:41:30 PM
From: jim black	Read Replies (1) \| Respond to of 36161

Well, Russ, I salute your model and wish you well. Just because a biotech has affiliation with the likes of Pfizer have not been good to my personal risk taking in the past, to wit, one Neurogen, many on the Board being in the past at least on the faculty of Yale. You have iron cojones and you are a braver man than I. Good luck. Incidentally, begging you not to take offense at the caveat, I remind you that many promising drugs that reach phase III only then show the unacceptable side effects. For the life of me I still cannot fathom why any doctor in neurology would use the anticonvulsant drug vigabatrine due to a 40% occurrence of significant and permanent visual field defects. That is the other big oft neglected danger in gambling on biotech stories that reach a drug comapny...lawsuits, successful ones, for example Merrill, years ago bankrupt and bought out, now absorbed within Marion Merrill Dow for ONE CASE of allegedly drug induced birth defect blamed on Bendectin...Hell! !!90 MILLION !!! for one case in one kid. I didn't buy it then and I don't buy it now. EVERYBODY used that drug for years for morning sickness, but we(I) digress...you sound like you know what your game is, have the courage to play it, and the fortitude to live with your choices. I wish you a billion bucks and a sunny weekend. Jim